- Training
- September 2023
- 2 Days
Global
From €1403EUR$1,470USD£1,175GBP
- Training
- July 2023
- 2 Days
Global
From €2768EUR$2,900USD£2,319GBP
- Webinar
- July 2023
- 4 Hours
Global
From €702EUR$736USD£588GBP
- Training
- May 2023
- 2 Days
Global
From €1406EUR$1,474USD£1,178GBP
- Training
- March 2023
- 3 Hours
Global
From €1168EUR$1,224USD£979GBP
- Training
- March 2023
- 3 Days
Global
€2226EUR$2,332USD£1,865GBP
- Webinar
- May 2022
- 1 Hour
Global
From €477EUR$500USD£400GBP
- Webinar
- March 2019
- 60 Minutes
Global
- Webinar
- February 2019
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 9 Hours
Global
€1240EUR$1,299USD£1,039GBP
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
From €1908EUR$1,999USD£1,598GBP
- Training
- 3 Hours
Global
- Training
- 2 Hours
Global

Good Documentation Practice (GDP) is a set of principles and guidelines used in the pharmaceutical manufacturing industry to ensure the accuracy, completeness, and consistency of documents. It is designed to ensure that all documents related to the manufacturing process are accurate, up-to-date, and compliant with regulatory requirements. GDP is an important part of the quality assurance process, as it helps to ensure that the products produced are safe and effective.
GDP includes a range of activities, such as document control, document review, document archiving, and document management. It also includes the use of electronic systems to store and manage documents, as well as the use of digital signatures to ensure the authenticity of documents.
GDP is an essential part of the pharmaceutical manufacturing process, as it helps to ensure that the products produced are safe and effective. It is also important for companies to ensure that their documents are compliant with regulatory requirements.
Some companies in the Good Documentation Practice market include MasterControl, ValGenesis, and PharmaLex. Show Less Read more